胃內滯留給藥系統的全球市場（2021-2027）

在預測期內（2021-2027 年），全球胃內滯留給藥系統市場預計將以 6.3% 的中等複合年增長率增長。支持該市場增長的是胃內滯給藥系統相對於低生物利用度藥物的各種優勢，這些藥物在醫療領域用於治療胃部疾病，採用給藥系統的案例數量正在增加。此外，發展中國家大公司加大對先進給藥系統研發活動的投資也在推動市場增長。主要國家醫療基礎設施的發展以及主要參與者引入新的給藥系統將為預測期內的市場增長提供有利機會。在發展中國家，患者對胃內滯留給藥系統的認識不足可能會在預測期內阻礙市場增長。

在 COVID-19 危機期間，全球胃吸附劑市場略有下滑。主要國家原材料供應鏈的中斷影響了新設備的生產。然而，由於在線藥物管理和處方的增加，對市場的影響正在減弱。

全球胃內滯給藥系統市場根據類型、劑型和分銷渠道進行分類。按類型，它們可分為高密度系統、可擴展藥物遞送系統、生物粘附藥物遞送系統、浮游藥物遞送系統等。其中，浮動給藥系統預計將在 2020 年佔據市場主導地位，並在預測期內保持主導地位。根據劑量方案，市場分為膠囊、微球、片劑、液體等。由於製造商增加胃吸附片的產量，預計片劑部分將佔據最大的市場份額。同樣，根據分銷渠道，市場分為零售藥店、在線藥店和醫院藥店。在預測期內，醫院部門預計將在其他分銷渠道中佔據首位。

本報告調查了胃滯留給藥系統的全球市場，提供了市場概況，按類型、劑量方案、分銷渠道和地區分析了市場增長和障礙、市場機會和市場規模。它提供了系統的信息例如趨勢和預測、競爭條件以及主要公司的概況。

目錄

第 1 章報告概述

第 2 章市場概覽和洞察

• 調查範圍
• 分析師洞察和當前市場趨勢

第 3 章競爭形勢

• 主要公司分析
  • 概述
  • 財務分析
  • SWOT 分析
• 重要的戰略分析
• COVID-19 對主要參與者的影響

第 4 章市場決定因素

• 增長因素
• 抑制因素
• 市場機會

第 5 章市場細分

• 按類型
  • 高密度系統
  • 可擴展的給藥系統
  • 生物粘附給藥系統
  • 浮動給藥系統
  • 其他
• 按劑型
  • 膠囊
  • 球體
  • 錠
  • 液體
  • 其他
• 按分銷渠道
  • 零售藥店
  • 醫院藥房
  • 網上藥店

第 6 章區域分析

• 北美
  • 美國
  • 加拿大
• 歐洲
  • 英國
  • 德國
  • 意大利
  • 西班牙
  • 法國
  • 其他歐洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 東盟
  • 韓國
  • 其他亞太地區
• 其他領域

第 7 章公司簡介

• Alcon Vision LLC
• Assertio Holdings, Inc.
• F. Hoffmann La Roche
• GlaxoSmithKline PLC
• Lupin
• Pfizer Inc
• Pharmacia
• Sun Pharmaceutical Industries Ltd

Full-title:Global Gastroretentive Drug Delivery Systems Market Size, Share & Trends Analysis Report By Type (High-Density Systems, Expandable Drug Delivery Systems, Bioadhesive Drug Delivery Systems, Floating Drug Delivery Systems and Others) By Dosage Forms (Tablets, Liquid, Microspheres, Capsule, and Others) By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies) Forecast, 2021-2027.

The global gastroretentive drug delivery systems market is projected to grow at a modest CAGR of 6.3% during the forecast period (2021-2027). The key aspect that drives the growth of the market includes the various advantages possessed by the gastroretentive drug delivery systems for the drug with poor bioavailability due to which their adoption is increasing in the healthcare sector for the treatment of gastric disorders. Moreover, the rising investment in R&D activities for advanced drug delivery systems by the major players in developing countries is also propelling the market growth. The development in healthcare infrastructures in major economies, and the introduction of new drug delivery systems by key players will offer lucrative opportunities in the growth of the market during the forecast period. The lack of awareness about gastroretentive drug delivery systems among patients in under developing countries may be projected to hinder the market growth during the forecast period.

The global gastroretentive drug delivery systems market suffered a mild downfall during the COVID-19 crisis. The disruption in the supply chain of raw materials from the major countries has affected the manufacturing of new devices. Despite this, the increase in online drug delivery and prescription leads to less impact on the market.

The global gastroretentive drug delivery systems market is segmented based on type, dosage form, and distribution channel. Based on type, the market is segregated into high-density systems, expandable drug delivery systems, bioadhesive drug delivery systems, floating drug delivery systems, and others. Among these, the floating drug delivery system dominated the market in 2020, and it is further anticipated to maintain its dominant position during the forecast period. Based on dosage form, the market is categorized into capsule, microspheres, tablets, liquid, and others. The tablet segment is expected to account for the largest share in the market due to the increasing manufacturing of gastroretentive tablets by manufacturers in the market. Likewise, based on distribution channels, the market is categorized into retail pharmacies, online pharmacies, and hospital pharmacies. The hospital segment is projected to gain the leading position among other distribution channels during the forecast period.

Geographically market is segmented into four key regions including North America, Europe, Asia Pacific, and the Rest of the World.& North America is estimated to dominate the market by accounting largest revenue share in the market. The factors attributed to the growth of the market include the rising geriatric population coupled with gastric disorders and increasing high expenditure in R&D activities by key players. The Asia Pacific is the fastest-growing market for the gastroretentive drug delivery systems market. The development in healthcare infrastructure, the presence of a large patient pool, and the growing demand for such effective systems will augment the growth of the market.

Further, F. Hoffmann-La Roche AG, Sun Pharmaceutical Industries Ltd., GlaxoSmithKline PLC, Assertio Holdings, Inc., Alcon Vision LLC, Lupin, Pfizer Inc., and others are some of the prominent players functioning in the global gastroretentive drug delivery systems market. These market players are highly inclined towards the adoption of marketing strategies such as new product launches, partnership collaboration, business expansion, mergers, and acquisition, among others. Adoption of such strategies supports these key players to remain in the competition and to generate large revenue. 

Research Methodology

The market study of the global gastroretentive drug delivery systems market is incorporated by extensive primary and secondary research conducted by the research team. Secondary research has been conducted to refine the available data to break down the market into various segments, derive total market size, market forecast, and growth rate. Different approaches have been worked on to derive the market value and market growth rate. Our team collects facts and data related to the market from different geography to provide a better regional outlook. In the report, the country-level analysis is provided by analyzing various regional players, regional tax laws and policies, consumer behavior, and macro-economic factors. Numbers extracted from secondary research have been authenticated by conducting proper primary research. It includes tracking down key people from the industry and interviewing them to validate the data. This enables our analyst to derive the closest possible figures without any major deviations in the actual number. Our analysts try to contact as many executives as possible, managers, key opinion leaders, and industry experts. Primary research brings the authenticity of our reports.

Secondary Sources Include

• Financial reports of companies involved in the market.

• Whitepapers, research papers, and news blogs

• Company websites and their product catalog

The report provides an in-depth analysis of market size, intended quality of the service preferred by consumers. The report will serve as a source for a 360-degree analysis of the market thoroughly integrating different models.

Market Segmentation

• Global Gastroretentive Drug Delivery Systems Market Research and Analysis by Type

• Global Gastroretentive Drug Delivery Systems Market Research and Analysis by Dosage Forms

• Global Gastroretentive Drug Delivery Systems Market Research and Analysis by Distribution Channel

The Report Covers

• Comprehensive research methodology of the global Gastroretentive Drug Delivery Systems market.

• This report also includes a detailed and extensive market overview with key analyst insights.

• An exhaustive analysis of macro and micro factors influencing the market guided by key recommendations.

• Analysis of regional regulations and other government policies impacting the global Gastroretentive Drug Delivery Systems market.

• Insights about market determinants that are stimulating the global Gastroretentive Drug Delivery Systems market.

• Detailed and extensive market segments with regional distribution of forecast revenues.

• Extensive profiles and recent developments of the market players.

Table of Contents

1. Report Summary

• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Gastroretentive Drug Delivery Systems Industry
• Recovery Scenario of Global Gastroretentive Drug Delivery Systems Industry
• 1.1. Research Methods and Tools
• 1.2. Market Breakdown
  • 1.2.1. By Segments
  • 1.2.2. By Geography

2. Market Overview and Insights

• 2.1. Scope of the Report
• 2.2. Analyst Insight & Current Market Trends
  • 2.2.1. Key Findings
  • 2.2.2. Recommendations
  • 2.2.3. Conclusion

3. Competitive Landscape

• 3.1. Key Company Analysis
  • 3.1.1. Overview
  • 3.1.2. Financial Analysis
  • 3.1.3. SWOT Analysis
• 3.2. Key Strategy Analysis
• 3.3. Impact of COVID-19 on Key Players

4. Market Determinants

• 4.1. Motivators
• 4.2. Restraints
• 4.3. Opportunities

5. Market Segmentation

• 5.1. Global Gastroretentive Drug Delivery Systems Marketby Type
  • 5.1.1. High Density Systems
  • 5.1.2. Expandable Drug Delivery Systems
  • 5.1.3. Bioadhesive Drug Delivery Systems
  • 5.1.4. Floating Drug Delivery Systems
  • 5.1.5. Others
• 5.2. Global Gastroretentive Drug Delivery Systems Marketby Dosage form
  • 5.2.1. Capsule
  • 5.2.2. Microspheres
  • 5.2.3. Tablets
  • 5.2.4. Liquid
  • 5.2.5. Others
• 5.3. Global Gastroretentive Drug Delivery Systems Marketby Distribution Channel
  • 5.3.1. Retail Pharmacies
  • 5.3.2. Hospital Pharmacies
  • 5.3.3. Online Pharmacies

6. Regional Analysis

• 6.1. North America
  • 6.1.1. US
  • 6.1.2. Canada
• 6.2. Europe
  • 6.2.1. UK
  • 6.2.2. Germany
  • 6.2.3. Italy
  • 6.2.4. Spain
  • 6.2.5. France
  • 6.2.6. Rest of Europe
• 6.3. Asia-Pacific
  • 6.3.1. China
  • 6.3.2. India
  • 6.3.3. Japan
  • 6.3.4. ASEAN
  • 6.3.5. South Korea
  • 6.3.6. Rest of Asia-Pacific
• 6.4. Rest of the World

7. Company Profiles

• 7.1. Alcon Vision LLC
• 7.2. Assertio Holdings, Inc.
• 7.3. F. Hoffmann La Roche
• 7.4. GlaxoSmithKline PLC
• 7.5. Lupin
• 7.6. Pfizer Inc
• 7.7. Pharmacia
• 7.8. Sun Pharmaceutical Industries Ltd

LIST OF TABLES

• 1. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETRESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
• 2. GLOBAL HIGH DENSITY GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETRESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 3. GLOBAL EXPANDABLE DRUG DELIVERY GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETRESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 4. GLOBAL BIOADHESIVE DRUG DELIVERY GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETRESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 5. GLOBAL FLOATING DRUG DELIVERY GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 6. GLOBAL OTHERS GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 7. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETRESEARCH AND ANALYSIS BY DOSAGE FORM, 2020-2027 ($ MILLION)
• 8. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETFOR TABLETS RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 9. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETFOR LIQUID RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 10. GLOBALGASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETFOR MICROSPHERES RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 11. GLOBAL HID GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET FOR CAPSULES RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 12. GLOBAL HID GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET FOR OTHERS DOSAGE FORMS RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 13. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETRESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)
• 14. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETIN HOSPITAL PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 15. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETINRETAIL PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 16. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETIN ONLINE PHARMACIES MARKET RESEARCH AND ANALYSIS BY REGION, 2020-2027 ($ MILLION)
• 17. NORTH AMERICAN GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETRESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
• 18. NORTH AMERICAN GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETRESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
• 19. NORTH AMERICAN GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETRESEARCH AND ANALYSIS BY DOSAGE FORM, 2020-2027 ($ MILLION)
• 20. NORTH AMERICAN GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETRESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)
• 21. EUROPEAN GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETRESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
• 22. EUROPEAN GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETRESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
• 23. EUROPEAN GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETRESEARCH AND ANALYSIS BY DOSAGE FORM, 2020-2027 ($ MILLION)
• 24. EUROPEAN GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETRESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)
• 25. ASIA-PACIFIC GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETRESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
• 26. ASIA-PACIFIC GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETRESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
• 27. ASIA-PACIFIC GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETRESEARCH AND ANALYSIS BY DOSAGE FORM, 2020-2027 ($ MILLION)
• 28. ASIA-PACIFIC GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETRESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL, 2020-2027 ($ MILLION)
• 29. REST OF THE WORLD GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETRESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
• 30. REST OF THE WORLD GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETRESEARCH AND ANALYSIS BY DOSAGE FORM, 2020-2027 ($ MILLION)
• 31. REST OF THE WORLD GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETRESEARCH AND ANALYSIS BY DISTRIBUTION CHANNEL INDUSTRY, 2020-2027 ($ MILLION)

LIST OF FIGURES

• 1. IMPACT OF COVID-19 ON GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET, 2020-2027($ MILLION)
• 2. IMPACT OF COVID-19 ON GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETBY SEGMENT, 2020-2027($ MILLION)
• 3. RECOVERY OF GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET, 2021-2027(%)
• 4. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSHARE BY TYPE, 2020 VS 2027 (%)
• 5. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSHARE BY DOSAGE FORM, 2020 VS 2027 (%)
• 6. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSHARE BY DISTRIBUTION CHANNEL, 2020 VS 2027 (%)
• 7. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSHARE BY GEOGRAPHY, 2020 VS 2027 (%)
• 8. GLOBAL HIGH DENSITY GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSHARE BY REGION, 2020-2027 ($ MILLION)
• 9. GLOBAL EXPANDABLE DRUG DELIVERY GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSHARE BY REGION, 2020-2027 ($ MILLION)
• 10. GLOBAL BIOADHESIVE DRUG DELIVERY GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSHARE BY REGION, 2020-2027 ($ MILLION)
• 11. GLOBAL FLOATING DRUG DELIVERY GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSHARE BY REGION, 2020-2027 ($ MILLION)
• 12. GLOBAL OTHERS GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSHARE BY REGION, 2020-2027 ($ MILLION)
• 13. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET FOR TABLETS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
• 14. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET FOR LIQUID MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
• 15. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET FOR MICROSPHERES MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
• 16. GLOBAL HID GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET FOR CAPSULES MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
• 17. GLOBAL HID GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET FOR OTHERS DOSAGE FORMS MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
• 18. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET IN HOSPITAL PHARMACIES MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
• 19. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET IN RETAIL PHARMACIES MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
• 20. GLOBAL GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKET IN ONLINE PHARMACIES MARKET SHARE BY REGION, 2020-2027 ($ MILLION)
• 21. US GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSIZE, 2020-2027 ($ MILLION)
• 22. CANADA GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSIZE, 2020-2027 ($ MILLION)
• 23. UK GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSIZE, 2020-2027 ($ MILLION)
• 24. FRANCE GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSIZE, 2020-2027 ($ MILLION)
• 25. GERMANY GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSIZE, 2020-2027 ($ MILLION)
• 26. ITALY GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSIZE, 2020-2027 ($ MILLION)
• 27. SPAIN GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSIZE, 2020-2027 ($ MILLION)
• 28. ROE GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSIZE, 2020-2027 ($ MILLION)
• 29. INDIA GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSIZE, 2020-2027 ($ MILLION)
• 30. CHINA GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSIZE, 2020-2027 ($ MILLION)
• 31. JAPAN GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSIZE, 2020-2027 ($ MILLION)
• 32. ASEAN GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSIZE, 2020-2027 ($ MILLION)
• 33. SOUTH KOREA GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSIZE, 2020-2027 ($ MILLION)
• 34. REST OF ASIA-PACIFIC GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSIZE, 2020-2027 ($ MILLION)
• 35. REST OF THE WORLD GASTRORETENTIVE DRUG DELIVERY SYSTEMS MARKETSIZE, 2020-2027 ($ MILLION)